Genetic Manipulation Approaches to Enhance the Clinical Application of NK Cell-Based Immunotherapy
- PMID: 38142460
- PMCID: PMC10940834
- DOI: 10.1093/stcltm/szad087
Genetic Manipulation Approaches to Enhance the Clinical Application of NK Cell-Based Immunotherapy
Abstract
Natural killer (NK) cells are a subset of cytotoxic lymphocytes within the innate immune system. While they are naturally cytotoxic, genetic modifications can enhance their tumor-targeting capability, cytotoxicity, persistence, tumor infiltration, and prevent exhaustion. These improvements hold the potential to make NK-cell-based immunotherapies more effective in clinical applications. Currently, several viral and non-viral technologies are used to genetically modify NK cells. For nucleic acid delivery, non-viral methods such as electroporation, lipid nanoparticles, lipofection, and DNA transposons have gained popularity in recent years. On the other hand, viral methods including lentivirus, gamma retrovirus, and adeno-associated virus, remain widely used for gene delivery. Furthermore, gene editing techniques such as clustered regularly interspaced short-palindromic repeats-based, zinc finger nucleases, and transcription activator-like effector nucleases are the pivotal methodologies in this field. This review aims to provide a comprehensive overview of chimeric antigen receptor (CAR) arming strategies and discuss key gene editing techniques. These approaches collectively aim to enhance NK cell/NK cell CAR-based immunotherapies for clinical translation.
Keywords: CAR-NK cells; CRISPR; cytokine-induced memory-like NK cells; gene delivery; gene editing; immunotherapy; natural killer cells.
© The Author(s) 2023. Published by Oxford University Press.
Conflict of interest statement
The author indicated no financial relationships.
Figures
Similar articles
-
Genetic reprogramming for NK cell cancer immunotherapy with CRISPR/Cas9.Immunology. 2019 Oct;158(2):63-69. doi: 10.1111/imm.13094. Epub 2019 Aug 14. Immunology. 2019. PMID: 31315144 Free PMC article. Review.
-
Non-viral approaches in CAR-NK cell engineering: connecting natural killer cell biology and gene delivery.J Nanobiotechnology. 2024 Sep 10;22(1):552. doi: 10.1186/s12951-024-02746-4. J Nanobiotechnology. 2024. PMID: 39256765 Free PMC article. Review.
-
Using Gene Editing Approaches to Fine-Tune the Immune System.Front Immunol. 2020 Sep 29;11:570672. doi: 10.3389/fimmu.2020.570672. eCollection 2020. Front Immunol. 2020. PMID: 33117361 Free PMC article. Review.
-
Therapeutic potential of CRISPR/CAS9 genome modification in T cell-based immunotherapy of cancer.Cytotherapy. 2024 May;26(5):436-443. doi: 10.1016/j.jcyt.2024.02.014. Epub 2024 Feb 23. Cytotherapy. 2024. PMID: 38466263 Review.
-
Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor-natural killer cells.Cytotherapy. 2022 Nov;24(11):1087-1094. doi: 10.1016/j.jcyt.2022.07.008. Epub 2022 Aug 29. Cytotherapy. 2022. PMID: 36050244
Cited by
-
Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer.Microorganisms. 2024 Jan 22;12(1):230. doi: 10.3390/microorganisms12010230. Microorganisms. 2024. PMID: 38276215 Free PMC article. Review.
-
Current status and future directions of nanovaccine for cancer: a bibliometric analysis during 2004-2023.Front Immunol. 2024 Jul 29;15:1423212. doi: 10.3389/fimmu.2024.1423212. eCollection 2024. Front Immunol. 2024. PMID: 39136021 Free PMC article. Review.
-
Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.Cells. 2024 Mar 5;13(5):451. doi: 10.3390/cells13050451. Cells. 2024. PMID: 38474415 Free PMC article. Review.
-
Three-Dimensional Model Analysis Revealed Differential Cytotoxic Effects of the NK-92 Cell Line and Primary NK Cells on Breast and Ovarian Carcinoma Cell Lines Mediated by Variations in Receptor-Ligand Interactions and Soluble Factor Profiles.Biomedicines. 2024 Oct 20;12(10):2398. doi: 10.3390/biomedicines12102398. Biomedicines. 2024. PMID: 39457710 Free PMC article.